Concomitant seminal vesicle invasion in pT4a urothelial carcinoma of the bladder with contiguous prostatic infiltration is an adverse prognosticator for cancer-specific survival after radical cystectomy
- PMID: 24895114
- DOI: 10.1245/s10434-014-3827-y
Concomitant seminal vesicle invasion in pT4a urothelial carcinoma of the bladder with contiguous prostatic infiltration is an adverse prognosticator for cancer-specific survival after radical cystectomy
Abstract
Purpose: To evaluate the prognostic value of concomitant seminal vesicle invasion (cSVI) in patients with urothelial carcinoma of the bladder (UCB) and contiguous prostatic stromal infiltration in a large cystectomy series.
Methods: A total of 385 patients with UCB and contiguous prostatic infiltration comprised our study. Patients were divided in two groups according to cSVI. Median follow-up was 36 months (interquartile range 11-74); the primary end point was cancer-specific mortality. The prognostic impact of cSVI was evaluated using multivariable Cox regression analysis. The predictive accuracy was assessed by a receiver operating characteristic analysis.
Results: A total of 229 patients (59.5 %) without cSVI comprised group A, and 156 patients (40.5 %) with cSVI comprised group B. Positive lymph nodes (63 vs. 44 %, p < 0.001) and positive surgical margins (34 % vs. 14 %, p < 0.001) were more common in patients with cSVI. The 5- and 10-year cancer-specific survival rates were 41 % and 32 % (group A) and 21 and 17 % (group B) (p < 0.001). In multivariable analysis, pathological nodal stage (hazard ratio [HR] 2.19, p < 0.001), soft tissue surgical margin (HR 1.57, p = 0.010), clinical tumor stage (HR 1.46, p = 0.010), adjuvant chemotherapy (HR 0.40, p < 0.001), and cSVI (HR 1.69, p < 0.001) independently impacted cancer-specific mortality. The c-indices of the multivariable models with and without inclusion of cSVI were 0.658 (95 % confidence interval 0.60-0.71) and 0.635 (95 % confidence interval 0.58-0.69), respectively, resulting in a predictive accuracy gain of 2.3 % (p = 0.002).
Conclusions: In patients with UCB and prostatic stromal invasion, cSVI adversely affected cancer-specific survival compared to patients without cSVI. The inclusion of cSVI significantly improved the predictive accuracy of our multivariable model regarding survival.
Similar articles
-
Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladder.Urol Oncol. 2016 Oct;34(10):432.e1-8. doi: 10.1016/j.urolonc.2016.05.008. Epub 2016 Jun 6. Urol Oncol. 2016. PMID: 27283218
-
Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.J Urol. 2007 Dec;178(6):2308-12; discussion 2313. doi: 10.1016/j.juro.2007.08.023. Epub 2007 Oct 22. J Urol. 2007. PMID: 17936804
-
Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.BJU Int. 2016 Feb;117(2):272-9. doi: 10.1111/bju.12984. Epub 2015 May 24. BJU Int. 2016. PMID: 25381844
-
Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.J Urol. 2012 Dec;188(6):2046-54. doi: 10.1016/j.juro.2012.08.017. Epub 2012 Oct 18. J Urol. 2012. PMID: 23083867 Review.
-
[Analysis of 34 cases of infiltrating carcinoma of the bladder treated exclusively with partial cystectomy (part 1)].Arch Esp Urol. 1996 May;49(4):349-64. Arch Esp Urol. 1996. PMID: 8754191 Review. Spanish.
Cited by
-
Impact of surgical margin status on the outcome of bladder cancer treated by radical cystectomy: a meta-analysis.Oncotarget. 2017 Mar 7;8(10):17258-17269. doi: 10.18632/oncotarget.12907. Oncotarget. 2017. PMID: 27791991 Free PMC article.
-
Concomitant carcinoma in situ may not be a prognostic factor for patients with bladder cancer following radical cystectomy: a PRISMA-compliant systematic review and meta-analysis.World J Urol. 2020 Jan;38(1):129-142. doi: 10.1007/s00345-019-02738-2. Epub 2019 Mar 27. World J Urol. 2020. PMID: 30919100
-
Feasibility Study of a Novel Protease-Activated Fluorescent Imaging System for Real-Time, Intraoperative Detection of Residual Breast Cancer in Breast Conserving Surgery.Ann Surg Oncol. 2020 Jun;27(6):1854-1861. doi: 10.1245/s10434-019-08158-1. Epub 2020 Jan 2. Ann Surg Oncol. 2020. PMID: 31898104 Free PMC article.
-
Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy.Bladder Cancer. 2017 Jul 27;3(3):161-169. doi: 10.3233/BLC-160086. Bladder Cancer. 2017. PMID: 28824943 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical